Key takeaways
- Estradiol is only interpretable with the cycle day attached; through the reproductive years the table describes phases, not ages.
- Perimenopausal estradiol is chaotic rather than low — rising FSH drives peaks higher than a normal cycle produces, then levels crash when no follicle matures.
- Progesterone is usually the hormone that falls first, because it is made only after ovulation actually occurs.
- A single normal result rules very little out. Read it alongside FSH, luteal progesterone, testosterone with SHBG, and thyroid.
A woman comes in at 44 with sleep that has fallen apart, a temper she does not recognise and periods that have gone heavy and unpredictable. Her estradiol comes back squarely in the normal range, and she is told her hormones are fine. Both things are true. The chart below is genuinely useful, but only if you understand what it can and cannot tell you — because for roughly a decade of a woman's life, a single estradiol number is one of the least informative measurements in medicine.
Estrogen is three hormones, and one of them is what gets measured
"Estrogen" is a class, not a molecule. Three matter: estradiol (E2), the dominant and most potent form through the reproductive years and the one clinicians measure; estrone (E1), weaker, produced substantially in fat tissue and the predominant estrogen after menopause; and estriol (E3), weakest, mainly relevant in pregnancy.
That estrone detail explains something otherwise confusing. After the ovaries stop producing estradiol, adipose tissue continues converting adrenal androgens into estrone. Two postmenopausal women with the same estradiol can therefore sit in quite different estrogenic environments depending on body composition — which is part of why postmenopausal symptom severity varies so much between women whose lab reports look identical.
Estradiol by life stage
| Life stage | Age | Typical estradiol range |
|---|---|---|
| Pre-puberty | Before 10-12 | < 10 pg/mL |
| Follicular phase | Reproductive years | 30-100 pg/mL |
| Ovulation peak | Reproductive years | 200-400 pg/mL |
| Luteal phase | Reproductive years | 50-200 pg/mL |
| Early perimenopause | Mid-30s to early 40s | Erratic, often high |
| Late perimenopause | Late 40s | Swinging 20-300 pg/mL |
| Menopause (first year) | ~51 | < 30 pg/mL |
| Postmenopause | 52+ | < 10-20 pg/mL |
| On modern HRT | Post-menopause | 40-80 pg/mL (target) |
Read that table as a description of where a value is likely to sit, not as a verdict on whether a given value is acceptable. The reproductive-year rows are cycle phases, not ages, and a number is only interpretable if you know which day of the cycle it came from.
Decade by decade
Teens and twenties. Estradiol rises through puberty and takes two to three years to settle into a regular cyclical pattern. The twenties are the reference version: low during menses, climbing through the follicular phase, peaking at ovulation, plateauing through the luteal phase and falling before the next bleed.
Early thirties. Broadly similar for most women. Ovulation may become slightly less reliable late in the decade, and subtle changes in PMS are often the first thing noticed.
Late thirties to early forties. Early perimenopause typically begins here and is rarely recognised, because the symptoms do not match what people expect. Progesterone falls first, since it depends on a corpus luteum forming after ovulation, and cycles that do not ovulate produce none. Estradiol at this stage is frequently normal or high. The result — anxiety, disrupted sleep, intensified PMS, heavier bleeding — is the opposite of the "low estrogen" story most women have been told to look for.
Mid to late forties. Classic perimenopause. Estradiol swings hard, and cohort data following women through the transition shows trajectories that are anything but a smooth decline (Tepper et al., J Clin Endocrinol Metab 2012). Hot flashes, night sweats, mood volatility and irregular cycles emerge in this window.
Around 51, and after. Menopause is defined retrospectively, as twelve consecutive months without a period. Estradiol has settled at consistently low levels by then and stays there, which — after a decade of unpredictability — is at least a stable baseline to work from.
Why perimenopause is chaotic rather than low
This is the single most useful thing to understand, and it is a mechanical story. The ovary contains a finite follicle pool that depletes with age. As it does, the remaining follicles respond less readily, so the pituitary raises FSH to push harder. That elevated FSH can then recruit follicles more aggressively than a normal cycle would, producing estradiol peaks higher than anything seen in the twenties. When a follicle fails to mature, no corpus luteum forms, no progesterone follows, and estradiol falls off sharply instead of tapering.
So the system is not winding down gently. It is being driven harder and harder by a pituitary that is not getting the feedback it expects, against an ovary that responds inconsistently. That produces peaks, crashes and progesterone gaps in no fixed order — and it is why symptoms in this decade are volatile rather than steadily progressive, and why bleeding often gets heavier rather than lighter on the way out.
Important: a single estradiol reading in perimenopause can be actively misleading. The same woman can be measured near the top of that late-perimenopausal swing and near the bottom of it a fortnight apart. Neither is her "level." Symptoms, cycle history and the direction of travel carry more information than any one draw.
How to test, and when the number is worth something
- If cycling regularly: day 3 and day 21 captures follicular and luteal phases, which is the only way to see the shape rather than a point.
- If perimenopausal: a single draw is often uninterpretable. Test if there is a specific question to answer, and weight the symptom picture more heavily than the value.
- If postmenopausal: any day works, because levels are stable.
- Ask for a mass spectrometry assay where available — LC-MS/MS is more accurate than standard immunoassays, particularly at the low concentrations that matter after menopause (Ketha & Singh, Steroids 2015).
Estradiol alone answers almost nothing. A complete panel adds FSH, which rises as ovarian responsiveness falls and is the marker the staging criteria lean on (Harlow et al., J Clin Endocrinol Metab 2012) — above roughly 25 mIU/mL suggests late perimenopause and above 40 suggests menopause; LH; progesterone, drawn in the luteal phase, which is what identifies the earliest change; total and free testosterone with SHBG; DHEA-S; and a full thyroid panel, because thyroid dysfunction produces a symptom set almost indistinguishable from this one and is far easier to fix.
Two different symptom patterns
Low estradiol produces hot flashes and night sweats, vaginal dryness and painful sex, disrupted sleep, low mood and irritability, brain fog, joint aches, accelerated bone loss, thinning skin and hair, urinary urgency and recurrent UTIs, and abdominal weight gain.
Erratic or high estradiol — the perimenopausal pattern — produces heavy or unpredictable bleeding, breast tenderness, migraines, bloating, palpitations and worsening PMS. Treating the second pattern as though it were the first is a common and unhelpful mistake; the woman with breast tenderness and flooding periods does not need more estrogen, she usually needs the progesterone her cycles have stopped producing. Perimenopause versus menopause separates the two properly.
Targets on hormone therapy
Modern hormone therapy aims to restore a physiologic level, not to recreate reproductive-age peaks — typically an estradiol somewhere around 40-80 pg/mL, with progesterone dosed separately and low-dose testosterone considered where there are documented androgen-deficiency symptoms. The goal is symptom control and skeletal protection at the lowest level that achieves them, decided against the individual's history (The Menopause Society, Menopause 2022). Timing matters as much as level — when to start and the complete HRT guide cover how that judgement is made.
Bottom line
The chart tells you where a value usually sits; it does not tell you whether yours is a problem. Through the reproductive years estradiol is only interpretable with the cycle day attached. Through perimenopause it is genuinely erratic — driven high by rising FSH, crashing when ovulation fails — so a single normal result rules nothing out, and progesterone is usually the hormone that fell first. After menopause it is stable and low, and the question shifts from measurement to whether replacement is appropriate. Run the full panel, read it against symptoms and cycle history, and treat the number as one input rather than the answer. The perimenopause guide and symptom quiz are the practical next steps.
Educational content, not medical advice. Laboratory interpretation and any treatment decision are made by a licensed physician after individual evaluation. Individual results vary.
